Form 4: Progyny Director Roger C. Holstein Receives Significant Equity Compensation

Progyny, Inc. Director Roger C. Holstein was granted 8,026 restricted stock units and options to purchase 37,234 shares of common stock on May 22, 2025, as part of his compensation.

Summary

• Roger C. Holstein, a Director at Progyny, Inc. (PGNY), acquired 8,026 shares of common stock in the form of Restricted Stock Units (RSUs) on May 22, 2025. These RSUs represent a contingent right to receive one share of common stock each and will vest on May 22, 2026, contingent on his continued service.
• Additionally, Mr. Holstein was granted stock options to purchase 32,834 shares of common stock with an exercise price of $20.89 per share on May 22, 2025. These options will vest on May 22, 2026, subject to his continued service.
• He also received another grant of stock options for 4,400 shares of common stock, also with an exercise price of $20.89 per share, on May 22, 2025. These options will vest 25% on the first anniversary of the grant date, with the remainder vesting in equal quarterly installments through the fourth anniversary of the grant date, subject to his continued service.
• Following these transactions, Mr. Holstein directly beneficially owns 21,937 shares of common stock, 32,834 stock options, and 4,400 stock options.

Sentiment

Score: 6

Explanation: The sentiment is moderately positive as it indicates a director receiving equity compensation, aligning their interests with shareholders. However, it's a routine compensation event rather than a significant operational or financial announcement.

Positives

• The grant of equity awards to a director aligns his interests with those of the company's shareholders, promoting long-term value creation.
• The compensation package includes both Restricted Stock Units (RSUs) and stock options, providing a balanced incentive structure with both immediate value and performance-based upside potential.

Negatives

• The equity grants represent potential future dilution for existing shareholders if all options are exercised and RSUs vest.
• These are compensation-related grants rather than open market purchases, which might be interpreted as a less direct signal of personal conviction in the stock's immediate performance.

Risks

• The vesting of both the Restricted Stock Units and stock options is contingent upon Roger C. Holstein's continued service to Progyny, Inc., meaning the awards could be forfeited if his service ceases before the specified vesting dates.
• The ultimate value realized from the stock options is dependent on Progyny, Inc.'s common stock price exceeding the exercise price of $20.89 per share in the future.

Future Outlook

NA

Industry Context

This Form 4 filing details routine equity compensation for a director, which is a common practice across industries to align management and board interests with shareholder value. It does not provide specific industry-wide insights beyond standard compensation practices.

Stakeholder Impact

• Shareholders: Potential future dilution from the vesting and exercise of equity awards, but also increased alignment of a director's interests with shareholder value.
• Employees: No direct impact on general employees mentioned in this filing.

Next Steps

• Continued service by Roger C. Holstein to ensure the vesting of his equity awards.
• Future reporting of any changes in beneficial ownership by Roger C. Holstein as required by SEC regulations.

Key Dates

Recommendation

Keywords

Progyny, PGNY, SEC Form 4, Insider Transaction, Restricted Stock Units, RSUs, Stock Options, Equity Grant, Director Compensation, Beneficial Ownership